RT @felly500: AZ / Oxford vaccine efficacy https://t.co/CXDKTeGWVQ https://t.co/RG3gzGrYde
RT @CristinaDragani: @Fabio_DAmico50 @RobertoBurioni Grazie per avermi taggata, ma avevo già riportato la notizia: https://t.co/3QKUHzXnpp
@Detroit67Book @nytimes https://t.co/lYSqNjeFEu @jasonleitch
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
#COVID19 🔴 @TheLancet publie les résultats des essais du #Vaccin @AstraZeneca @UniofOxford 🔴 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials https://t.co/kLpPlG
@Fabio_DAmico50 @RobertoBurioni Grazie per avermi taggata, ma avevo già riportato la notizia: https://t.co/3QKUHzXnpp
Les premiers résultats évalués par des pairs des essais humains de phase 3 du vaccin contre le coronavirus d'Oxford démontrent leur efficacité | Université d'Oxford
Another point of view ( underscoring positive findings) of the Oxford/AZ vaccine trial
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @aforista_l: - Prima di vaccinarmi voglio vedere i dati. - Guarda, quelli del #vaccino Oxford-AZ sono appena usciti sul Lancet, li trovi…
#Safety and #efficacy of the ChAdOx1 nCoV-19 #vaccine (AZD1222) against #SARSCoV2: an interim analysis of four #RandomisedControlTrials in Brazil, South Africa, and the UK https://t.co/GCfQaFD13T @TheLancet #OxfordVaccine https://t.co/uDNfXmPK0Q
#update #vaccine #SARS_CoV_2 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet @MIUI| https://t.co/VT820xaoau
RT @CaKizil: Oxford aşısının analizi @TheLancet dergisinde yayımlandı. Çalışma, aşının güvenli ve etkili olduğunu belirtiyor. Oldukça güzel…
RT @TheLancetInfDis: Just published @TheLancet: Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim…
First peer-reviewed results of phase 3 human trials of Oxford #vaccine| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK-The Lancet
RT @Antonio_Caramia: Grande @GiacomoGorini! Attendiamo con ansia il 29 dicembre 🤞
RT @vass_vassiliou: The Oxford @AstraZeneca vaccine study out @lancet! https://t.co/6xVBEKRqNT DEFINITELY WORTH A READ! The data are out,…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/dGufpu0c5f
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
First published study on vaccine efficiency and safety. The Oxford vaccine was 60-90% effective against symptomatic infections and 60% effective in the prevention of asymptomatic infections which is pretty amazing. https://t.co/4TejYkb8kM
RT @prieto_alhambra: Informe complet i 'peer reviewed' d'eficàcia i seguretat de l'anomenada "vacuna d'Oxford" (ChadOx1), ja disponibles a…
RT @cmgorriaran: Para quienes quieren más información: The Lancet, una de las primeras revistas de medicina independiente del mundo (una re…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
RT @adamhfinn: Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
More and more great Oxford vaccine data “Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet” https://t.co/7e8yWgcFOO
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @aforista_l: - Prima di vaccinarmi voglio vedere i dati. - Guarda, quelli del #vaccino Oxford-AZ sono appena usciti sul Lancet, li trovi…
RT @MJA_Editor: OXFORD/AZ VACCINE. 2 standard doses: vaccine efficacy 62% (27/4440 in vaccine vs 71/4455 in control). From 21 days after 1s…
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
RT @surzua_chile: La vacuna funciona. Fuente: artículo en The Lancet. https://t.co/t9Uoc8hzh5 https://t.co/gyRR69fwIM
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @EkateriniL: @ch_petrou @Dietis_Lab_UCY
@99freemind The vaccine has been tested, like any other, according to The Lancet: https://t.co/g8pKelhDK6
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
RT @aforista_l: - Prima di vaccinarmi voglio vedere i dati. - Guarda, quelli del #vaccino Oxford-AZ sono appena usciti sul Lancet, li trovi…
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/x0ycSGKOPq
RT @aforista_l: - Prima di vaccinarmi voglio vedere i dati. - Guarda, quelli del #vaccino Oxford-AZ sono appena usciti sul Lancet, li trovi…
RT @dclovesgp: congratulations to the team- thanks Sheffield academics- Tom Dalton et all and volunteers too- proud of your local effort an…
RT @vass_vassiliou: The Oxford @AstraZeneca vaccine study out @lancet! https://t.co/6xVBEKRqNT DEFINITELY WORTH A READ! The data are out,…
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @adamhfinn: Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
RT @cdanicas: First #COVID19 vaccine trial published! Interim analysis !! @OncoAlert @OncoReporte @PGrivasMDPhD @neerajaiims @DrChoueiri
RT @adamhfinn: Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
RT @adamhfinn: Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
RT @adamhfinn: Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
RT @k_pyrc: Pierwsze pełne dane - AstraZeneca x skuteczność 62% x częściowo《 szansa na zakażenie x zamieszanie z dawkami = błędna metoda m…
RT @nataliexdean: Out in @TheLancet, results from the Oxford/AZN trials, including more detail on the low dose results. Notably, the low do…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @adamhfinn: Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
Interim phase 3 efficacy and safety data on ChAdOx/AZ vaccine published in Lancet yesterday afternoon https://t.co/IMa1ld56C7
RT @pawinpawin: ยังไม่ทันขาดคำ วัคซีนของทาง Oxford ที่เราซื้อผลก็ออกมาแล้วเหมือนกันครับ
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
...
RT @sandyddouglas: Super-proud of our amazing team @JennerInstitute and @OxfordVacGroup , and all our partners😊 @AstraZeneca are committed…
RT @EricTopol: Just out @TheLancet: @AstraZeneca @UniofOxford vaccine interim trial results —Higher efficacy w/ low dose looks real, not li…
RT @drilkerbelek: Oxford-AstraZeneca aşısının faz-3 sonuçları Lancet'te yayımladı. Bu faz-3'ü yayımlanan ilk araştırma oluyor. Düşük doz il…
RT @aforista_l: - Prima di vaccinarmi voglio vedere i dati. - Guarda, quelli del #vaccino Oxford-AZ sono appena usciti sul Lancet, li trovi…
- Prima di vaccinarmi voglio vedere i dati. - Guarda, quelli del #vaccino Oxford-AZ sono appena usciti sul Lancet, li trovi a questo link: https://t.co/s5SM4rMldn - Eh, ma sono in inglese.
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
👏
Oxford-AstraZeneca Vaccine phase 3 results: https://t.co/2UlYGAufuS
RT @jmmasencio: Este es el camino, no las notas de prensa. NO obstante, son resultados preliminares aún...y lo más importante, muchas pregu…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
Safety and efficacy of the #ChAdOx1 nCoV-19 vaccine (#AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/KJnstNfXh6
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
[Articles] Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/ziAN3ky1PN
RT @rasittukel: Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen…
Oxford-AstraZeneca tarafından geliştirilen viral vektör aşısının faz III sonuçları Lancet’te yayımlandı. Düşük doz verilen ilk aşıdan sonra, ikinci aşı standart dozda uygulandığında %90 oranında koruyuculuk sağlanıyor. https://t.co/4Iq5GYcgHl
RT @Emrah_Altindis: Lancet dergisine Oxford asisi faz III calismalarinin ilk sonuclari yayinlandi. Faz III ilk sonuclari bilimsel metodla a…
@budino_antonio @ORGULLOVIKING13 Yo desde luego espero no hacerlo de los primeros. Aún así creo que el problema está en la desconfianza que nos merecen quienes hasta la fecha poco o nada han hecho bien, además de mentir. Personalmente creo que la vacuna se
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @drmikefraser: Safety and efficacy of the #ChAdOx1 nCoV-19 vaccine (#AZD1222) against SARS-CoV-2: an interim analysis of four randomised…
RT @ajpollard1: Dedicated to our friends and colleagues who have lost their lives during the pandemic https://t.co/Y70OyvbwOK
RT @cllrbartington: Peer-reviewed findings of the Oxford -AstraZeneca COVID-19 vaccine trial published in @TheLancet 👇 https://t.co/kPIjoS3…
RT @mjcthomas74: https://t.co/P26BEDDLDg Oxford vaccine study published its safe and effective 😀. Congratulations to all involved, feel ve…
@Pediatria @CAV_AEP Y en la cuenta de Twitter de @TheLancet https://t.co/YaJ0JJpTZx
RT @DelthiaRicks: From the Lancet: Astra Zeneca/Oxford Univ's Covid vaccine is safe & prompts an immune response against symptomatic diseas…
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…
RT @GiacomoGorini: Ecco qua, i dati di efficacia fase III del vaccino Oxford-AZ pubblicati proprio adesso sul Lancet! Ora tutta la comunità…
RT @iamyourgasman: Only science (and some luck 😅) will get us out of this mess. Happy reading the hundreds of pages in the appendix, where…
RT @Emrah_Altindis: Lancet dergisine Oxford asisi faz III calismalarinin ilk sonuclari yayinlandi. Faz III ilk sonuclari bilimsel metodla a…
Update on Vaccine.
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK https://t.co/7VAiMsGmVP @AnilSinghvi_
RT @TheLancet: NEW—First full results from interim analysis confirm that the Oxford #COVID19 vaccine is safe and efficacious against sympto…